{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:05:50Z","timestamp":1783109150138,"version":"3.54.6"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The emergence of multidrug resistance in <jats:italic>N. gonorrhoeae<\/jats:italic> is a serious global problem, and gonorrhea may soon become an incurable disease. The aim of the study was to characterize the <jats:italic>N. gonorrhoeae<\/jats:italic> population in Russia from 2015 to 2023 and predict the potential spread of the most concerning clones.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 996\u00a0N<jats:italic>. gonorrhoeae<\/jats:italic> isolates were examined during the analyzed period. Ceftriaxone and azithromycin susceptibility testing were performed using the agar dilution method. Microarray-based assays and sequencing were employed to identify the genotypes and genetic markers of antimicrobial resistance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No ceftriaxone-resistant isolates were found in Russia, however, the number of isolates with reduced susceptibility to ceftriaxone has increased to 22.6% in recent years. Since 2020, approximately 12.5% of isolates have exhibited resistance to azithromycin annually. Two clusters of isolates pose a particular threat to Russia: NG-MAST G2212, linked to MLST 1901\/1902, carries a mosaic structure in the <jats:italic>penA<\/jats:italic> gene; G12302, linked to MLST 9363, contains mosaic alleles in the <jats:italic>mtrR<\/jats:italic> and <jats:italic>mtrD<\/jats:italic> genes. Additionally, two new high-risk genogroups were characterized: G18898 and G16206. Both are associated with MLST 10314 and harbor mosaic variants of <jats:italic>penA<\/jats:italic> or <jats:italic>mtrR<\/jats:italic>\/<jats:italic>mtrD<\/jats:italic>. Analysis of time series data suggests that isolates with mosaic alleles are unlikely to be eradicated from the population in the near future, potentially worsening the epidemiological situation of gonorrhea in Russia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The native genetic strains of <jats:italic>N. gonorrhoeae<\/jats:italic> in Russia, which are susceptible to cephalosporins and macrolides, are being progressively replaced by globally dominant lineages. To further characterize this epidemiologic shift, ongoing surveillance strategies using molecular epidemiology and the identification of genetic markers will be crucial in curbing the growth and spread of <jats:italic>N. gonorrhoeae<\/jats:italic> resistance. Such efforts are vital in ensuring the availability of effective treatments for gonococcal infection.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1526859","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T06:48:53Z","timestamp":1739947733000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular epidemiology of Neisseria gonorrhoeae isolates in Russia, 2015\u20132023: current trends and forecasting"],"prefix":"10.3389","volume":"15","author":[{"given":"Ilya","family":"Kandinov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Shaskolskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Kravtsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoliy","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Kubanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Shpilevaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Shagabieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Nosov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Gryadunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1093\/cid\/ciac043","article-title":"Management of Neisseria gonorrhoeae in the United States: summary of evidence from the development of the 2020 gonorrhea treatment recommendations and the 2021 centers for disease control and prevention sexually transmitted infection treatment guidelines","volume":"74","author":"Barbee","year":"2022","journal-title":"Clin. Infect. diseases: an Off. Publ. Infect. Dis. Soc. America"},{"key":"B2","volume-title":"Gonococcal antimicrobial susceptibility surveillance in the European Union\/European Economic Area 2022","year":"2024"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae369","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae detected in England 2015-24: an observational analysis","volume":"79","author":"Fifer","year":"2024","journal-title":"J. antimicrobial chemotherapy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1016\/S2666-5247(23)00370-1","article-title":"Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study","volume":"5","author":"Golparian","year":"2024","journal-title":"Lancet Microbe"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.32607\/20758251-2018-10-4-4-18","article-title":"The EIMB hydrogel microarray technology: thirty years later","volume":"10","author":"Gryadunov","year":"2018","journal-title":"Acta naturae"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1093\/infdis\/jiaa002","article-title":"Neisseria gonorrhoeae population genomics: use of the gonococcal core genome to improve surveillance of antimicrobial resistance","volume":"222","author":"Harrison","year":"2020","journal-title":"J. Infect. Dis."},{"key":"B7","unstructured":"Hyndman\n              R. J.\n            \n            \n              Athanasopoulos\n              G.\n            \n          \n          Melbourne, Australia\n          OTexts\n          Forecasting: principles and practice\n          \n          2018"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11051226","article-title":"Emergence of azithromycin-resistant neisseria gonorrhoeae isolates belonging to the NG-MAST genogroup 12302 in Russia","volume":"11","author":"Kandinov","year":"2023","journal-title":"Microorganisms"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9110941","article-title":"Molecular Typing of Neisseria gonorrhoeae Clinical Isolates in Russia 2018-2019: A Link Between penA Alleles and NG-MAST Types","volume":"9","author":"Kandinov","year":"2020","journal-title":"Pathog. (Basel Switzerland)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115781","article-title":"Mini-multilocus sequence typing scheme for the global population of Neisseria gonorrhoeae","volume":"25","author":"Kandinov","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010170","article-title":"Azithromycin susceptibility testing and molecular investigation of Neisseria gonorrhoeae isolates collected in Russia 2020-2021","volume":"12","author":"Kandinov","year":"2023","journal-title":"Antibiotics (Basel Switzerland)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.25208\/vdv16795","article-title":"Dermatovenereology of the Russian federation: results of 2023","volume":"100","author":"Kubanov","year":"2024","journal-title":"Vestnik dermatologii i venerologii"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e02024","DOI":"10.1128\/JCM.02024-18","article-title":"Summary and trends of the Russian gonococcal antimicrobial surveillance programme 2005 to 2016","volume":"57","author":"Kubanov","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12879-016-1688-7","article-title":"Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status 2015)","volume":"16","author":"Kubanov","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.37.2300456","article-title":"Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023","volume":"28","author":"Maubaret","year":"2023","journal-title":"Euro surveillance"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae053","article-title":"High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia 2022-23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)","volume":"6","author":"Ouk","year":"2024","journal-title":"JAC-antimicrobial resistance"},{"key":"B17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.25208\/vdv1410","article-title":"Analysis of the dynamics of the IPC of antimicrobials against N. gonorrhoeae in the Russian Federation for the period 2005-2021","volume":"99","author":"Shagabieva","year":"2023","journal-title":"Vestnik dermatologii i venerologii"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2020.01.020","article-title":"Genetic diversity of Neisseria gonorrhoeae multi-antigen sequence types in Russia and Europe","volume":"93","author":"Shaskolskiy","year":"2020","journal-title":"Int. J. Infect. diseases: IJID: Off. Publ. Int. Soc. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220339","article-title":"Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia 2015-2017","volume":"14","author":"Shaskolskiy","year":"2019","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/jac\/dkab308","article-title":"Prediction of ceftriaxone MIC in Neisseria gonorrhoeae using DNA microarray technology and regression analysis","volume":"76","author":"Shaskolskiy","year":"2021","journal-title":"J. antimicrobial chemotherapy"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/polym13223889","article-title":"Hydrogel droplet microarray for genotyping antimicrobial resistance determinants in neisseria gonorrhoeae isolates","volume":"13","author":"Shaskolskiy","year":"2021","journal-title":"Polymers"},{"key":"B22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/infdis\/jiad258","article-title":"Antimicrobial Resistance Profiling and Genome Analysis of the penA-60.001 Neisseria gonorrhoeae Clinical Isolates in China in 2021","volume":"228","author":"Tang","year":"2023","journal-title":"J. Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1093\/jac\/dkae176","article-title":"The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization","volume":"79","author":"Unemo","year":"2024","journal-title":"J. antimicrobial chemotherapy"},{"key":"B24","unstructured":"Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections 2022\u20132030, Report on progress and gaps\n          \n          \n          \n          2024"},{"key":"B25","unstructured":"Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (syphilis) and new recommendations on syphilis testing and partner services\n          \n          \n          \n          2024"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1526859\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T06:48:58Z","timestamp":1739947738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1526859\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":25,"alternative-id":["10.3389\/fcimb.2025.1526859"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1526859","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"article-number":"1526859"}}